BACKGROUND {#s1}
==========

Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease, and it is associated high metabolic risk of health problem such as dyslipidemia, insulin resistance, obesity and type II diabetic disease. In parallel with the prevalence of metabolic syndrome, NAFLD comprised of a spectrum of fatty liver that encompasses three typical pathological subtypes including liver steatosis, non-alcoholic steatohepatitis (NASH) and fibrosis. The least severe stage is simple liver steatosis induced by a largely build-up of fat in liver cell ([@B17]). The progression of steatosis can be slowed or reversed by lifestyle modification and physical exercise. Otherwise, Non-Alcoholic Steatohepatitis (NASH), a severer form characterized by fat build-up, varying degrees of inflammation and ballooning degeneration of liver cells could be developed. More seriously, NASH continues to develop liver fibrosis and cirrhosis when the long term of liver injury leads to irreversible scarring of the liver ([@B7]). As the late stage of fibrosis, Cirrhosis could irreversibly disrupt liver function and finally increased the risk of hepatocellular carcinoma development in patients.

Currently, there is no pharmacological agent that is being officially approved in NAFLD therapy. For one thing, the recommended intervention in NAFLD is lifestyle modification including energy intake restriction and physical activity enhancement. Lifestyle modification can reduce body weight and a moderate decrease of body weight could improve hepatic pathologic syndrome and decrease hepatic fat accumulation. For the other thing, some pharmacological interventions classified as antioxidants, insulin sensitizers and lipid-lowering drugs have been applied. For example, the antioxidant reagent such as Vitamin E has been suggested to treat non-diabetic patients with NASH as evidenced by a recent clinical trial ([@B85]); The use of lipid-lowering agents such as statin has been shown to reduce the risk of mortality or liver transplant in NAFLD patients ([@B28]); As sodium-glucose co-transporter 2 (SGLT2) inhibitors, Dapagliflozin and Canagliflozin could decrease hepatic lipid accumulation and significantly improve liver function ([@B3]). However, Most of these pharmacological agents are still at various stages of new drug development. For example, the natural farnesoid X receptor (FXR) agonist (obeticholic acid) and dual peroxisome proliferator-activated receptor α-δ (PPARα-δ) agonist (elafibranor), as well as glucagon-like peptide-1 antagonists were still investigated in phase IIA or IIB clinical trials ([@B86]). Meanwhile, several anti-diabetic medications such as pioglitazone ([@B9]), metformin and thiazolidinediones have been applied for the pharmacologic management of NAFLD in clinical practice due to their ability to reverse insulin resistance. Although the advances in conventional medicine, herbal medicine are easily accessible and do not require artificial synthesis, thus herbal medicine seems highly attractive for the effective management of NAFLD. Herbal medicine, defined as whole medicinal plants and unpurified plant extracts with medical properties, has been traditionally used in different countries of the world to improve liver conditions. A special term Traditional Chinese Medicine (TCM) was particularly given to refer to herbal medicines that have been applied since the ancient time of China, though TCM might also include medicines with origins of animals and minerals. TCM includes various forms of herbal medicine that has been proved to take effects on treatment of NAFLD. In recent years, progress in drug development of NAFLD has been found major advances with herbal medicines which are regarded as abundant sources of natural bioactive chemicals that improve hepatic functions. In this paper, we have provided an overview of herbal medicine (including herbal formula, crude extract, and pure bioactive compound form medicinal plants) approaches which have demonstrated their ability to counteract NAFLD in human patients and animal models.

The Effective Management of Herbal Medicine on NAFLD {#s2}
====================================================

Herbal Medicine Improve Hepatic Lipid Metabolism {#s2_1}
------------------------------------------------

Overload lipid is the main initial reason that triggers hepatic steatosis. Excessive free fatty acids (FFAs) delivery from the adipose to the liver and result in the intrahepatic pool expansion of FFAs in the form of triglycerides. Fat accumulation evokes hepatic lipo-toxicity, which induces liver cells to release pro-inflammatory cytokines, trigger oxidative stress and hepatic stellate cell activation, ultimately lead to hepatic inflammatory injury. Improvement of fatty acid metabolism is an effective measure for in treating NAFLD, and the efficacy of herbal medicine targeting fatty acid metabolism has examined in both preclinical and clinical research of NAFLD. Firstly, The beneficial effects of herbal medicine on patients with liver dyslipidemia can improve lipid metabolic parameters such as decreasing the levels of triglycerides (TG), total cholesterol (TC) and low-density lipoprotein (LDL-C), alanine aminotransferase (ALT), aspartate aminotransferase (AST), as well as increasing the production of high-density lipoprotein (HDL-C). The interference of herbal medicine on dyslipidemia has been proved to be related to the regulation of fatty acid production or consumption. It has been found out that many herbal medicine (including herbal formula, crude extract and pure bioactive compound form medicinal plants) depressed the hepatic lipogenesis *via* reducing the expression of the key transcriptional factors and lipogenic enzymes such as Sterol Regulatory Element Binding Protein 1c (SREBP-1c), Peroxisome-Proliferator-Activated Receptor γ (PPAR-γ), Acetyl-CoA Carboxylase (ACC), Fatty Acid Synthase (FAS) and SCD1. For example, Gypenosides (extracted from *Gynostemma pentaphyllum*) ([@B55]), the chloroform fraction of *Cyclocarya paliurus* ([@B60]), total alkaloids extracted from *Rubus aleaefolius* Poir. ([@B54]), *Lonicera caerulea* L. extract ([@B79]) and the crude extract from the peels of *Citrus aurantium* L. *(Rutaceae*) ([@B31]) effectively attenuates high fat diet (HFD) induced triglyceride accumulation *via* reducing the high production of SREBP-1c, PPAR-γ, FAS, and ACC.

### AMPK Pathway Involves in Herbal Medicine Modulation of Hepatic Lipogenesis and β-Oxidation {#s2_1_1}

Adenosine monophosphate-activated Protein Kinase (AMPK) is a key energy sensor of intracellular energy metabolism, which could cause the reduction of cellular triglyceride and cholesterol production. The activation of AMPK phosphorylation could attenuate free fatty acid-regulated *de novo* lipogenesis genes and hepatic lipid accumulation. AMPK phosphorylation have been mentioned frequently in hepatic lipid metabolism to be activated in response to many herbal medicine such as BaiHuJia RenShen Decoction ([@B64]), Qushi Huayu Decoction ([@B25]), *Lonicera caerulea* L. extract ([@B79]), nobiletin (a polymethoxylated flavonoid derived from citrus fruits) ([@B116]), ginsenoside Rb1 ([@B87]), betulinic acid ([@B47]), and berberine ([@B126]). Sophocarpine (derived from foxtail-like sophora herb and seed) influences adipocytokine production *via* AMPK signaling in NASH rats ([@B92]), and salvianolic acid B (isolated from *Salvia miltiorrhiza* Bge.) reduces dyslipidemia and hyperglycemia *via* AMPK activation ([@B40]). It has been reported that some herbal medicine such as *Lonicera caerulea* L. extract ([@B79]) and methanolic extract of *Alisma orientalis* ([@B33]) increases fatty acid β-oxidation *via* activating lipid antioxidant enzymes such as Carnitine Palmitoyltransferase-1 (CPT-1) and lessening peroxidation. This beneficial effects of herbal medicine on β-oxidation involved the activation of AMPK/PPAR-α and its downstream pathway. For example, the methanolic extract of *Alisma orientalis* ([@B33]), the ethanol extract of *Leonurus japonicus* Houtt ([@B51]), *Lycopus lucidus* Turcz. ex Benth ([@B52]) and Hugan Qingzhi formula ([@B113]) increases hepatic β-oxidation *via* upregulation of the phosphorylated AMPK and PPARα expression ([@B12]; [@B51]). AMPK activation in hepatic lipid β-oxidation also requires the activity of silent information regulator 1 (SIRT1), which interferes with PPARs activation. Silibinin shows its potential natural antioxidant effects on restoration of NAD^+^ levels *via* AMPK/SIRT1 pathway. Licochalcone A (isolated from *Glycyrrhiza uralensis*) significantly induces the AMPK/SIRT-1 pathway to inhibit hepatic lipogenesis synthesis and improve β-oxidation ([@B62]). Dioscin mediated SIRT1/AMPK signal pathway and LXRα action ([@B13]) to modulate the expression of SREBP-1c, CPT-1, FAS, SCD, FoxO1, and ATGL([@B112]). Ursolic acid has been treated as a novel Liver X receptor α (LXRα) antagonist and Ursolic acid stimulated AMPK phosphorylation to inhibit steroid receptor coactivator-1 (SRC-1) recruitment and promote small heterodimer partner-interacting leucine zipper protein to the SREBP-1c promoter region ([@B61]). Thus, AMPK action activated by herbal medicine involves in *de novo* lipid synthesis associated with the suppression of SREBP-1c, FAS, ACC, and SCD-1expression, and increase β-oxidation defense that improves hepatic fatty acids efflux *via* the modulation of CPT-1 and PPARα production.

### Oxidative Stress Action Involves in Herbal Medicine Modulation of Lipid Metabolism {#s2_1_2}

Oxidative stress reflected an imbalance between the reactive species production and antioxidant defense, which can lead to liver damage in the progression of NAFLD. The lipid metabolic disorder influences the production of reactive oxygen species (ROS), specifically, fatty acid β-oxidation seems to generate more ROS in NAFLD. The lipid lowering effect of herbal medicine shows its correlation with anti-oxidative stress action. For example, Bangpungtongseong-san attenuates the transcriptional response of oxidative phosphorylation (OXPHOS) in NAFLD liver ([@B16]). Korea red ginseng shows anti-oxidant activity to improve hepatic lipid profiles in fatty rat ([@B35]). The ethyl acetate extract of *Aristolochia manshuriensis* Kom suppresses hepatic oxidative stress *via* improving the SOD, GR and GPx enzymes, subsequently increases hepatic lipid peroxidation of CYPE21 to promote hepatic lipolysis ([@B49]). LiGanShiLiuBaWei San can significantly promote fatty acid oxidation *via* activation of PPARα and PPARβ, and reduce oxidative stress *via* the inhibition of iNOS production ([@B44]). The down-regulation of hepatic HO-1, NF-E2-related factor 2 (Nrf2), and SOD2 as well as up-regulation KEAP1 were detected in the NAFLD models, and the expression of these oxidative stress markers can be all reversed by Dioscin ([@B65]). The Nrf2 activation mediated by herbal medicine can improve NAFLD *via* inhibiting oxidative stress pathway. It has been reported that scutellarin (a flavonoid glycoside), swertiamarin (a secoiridoid glycoside) ([@B109]) and gastrodin (isolated from *Gastrodia elata* Bl) enhance Nrf2-mediated antioxidant system *via* activating the mRNA and protein levels of PPARγ and its coactivator-1α, HO-1, GST, and NQO1 expressions ([@B2]), thus ameliorate NAFLD. Isochlorogenic acid B \[extracted from *Laggera alata* (Asteraceae)\] shows its protective effects on fibrosis in NASH by Nrf2 signaling pathway, and reverse the downregulation of miR-122 level and upregulation of hepatic HIF-1α expression to inhibit multiple profibrogenic factors (COL1α1, MCP-1, LOX, TGF-β1, and TIMP-1) ([@B69]).

### Mitochondria Function Involves in Herbal Modulation of Hepatic Lipid Metabolism {#s2_1_3}

Mitochondria plays a specialized role in lipid metabolism and could contact lipid droplets *via* Mitochondria oxidation in liver. Mitochondria dysfunction contribute to the progression of NAFLD since it influences hepatic lipid metabolism, promote the generation of ROS, and lipid peroxidation. Previous research has proved that herbal medicine such as *cyclocarya paliurus*, *sida rhomboidea*.roxb, *punica granatum* L., resveratrol, mangosteen pericarp, epigallocatechin gallate, and shexiang baoxin pill, were shown to be effective on mitochondrial dysfunction during treating the NAFLD ([@B108]). More detail, Shizukaol D (extracted from *Chloranthus japonicas*) improved mitochondrial dysfunction, leading to hepatic AMPK-dependent lipid content reduction ([@B39]). Polygonati Rhizoma and *Polygonatum kingianum* promote mitochondrial β-oxidation *via* increasing the CPT-1 activity to block long-chain fatty acid enter mitochondria, and improve mitochondrial function *via* inhibiting HFD-induced excessive production of ROS and malondialdehyde (MDA) ([@B108]). Nobiletin ([@B83]) and diosgenin ([@B24]) could lead to the reduction of ROS level and restoration of mitochondrial membrane potential. This mitochondrial interference suppressed lipid peroxidation that involved the increase of vital scavenger levels of glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD). Dioscin (isolated from *Polygonatum Zanlanscianense* Pamp) has been proved to increase the expression of SOD, GSH and GSH-Px, and decrease the production of iNOS, MDA and NO. Puerarin (extracted from Radix *Pueraria lobate*) evoked the activation of PARP-1/PI3K/AKT signaling that facilitated the transcripts (Acox1, MCAD, Cpt1 and Cox5a) in β-oxidation and reversed the decreased level of mitochondrial respiration complex I and II activities, further improved the fatty acid metabolism ([@B98]).

### Bile Acid Synthesis Involves in Herbal Medicine Modulation of Lipid Metabolism {#s2_1_4}

Bile acids are synthesized in the liver and act as biological detergent to metabolite lipids and cholesterol into the bile. Gypenosides (extracted from *Gynostemma pentaphyllum*) ([@B55]), palmatine and jatrorrhizine (extracted from Coptidis Rhizoma) promote bile acid synthesis to prevent NAFLD, which involved the expression of cholesterol 7α-hydroxylase A1 (CYP7A1). Punicalagin and pomegranate ellagic acid (isolated from *Punica granatum* L.) activate the CYP7A1/PPARγ signaling to promote hepatic diversion of cholesterol into bile acid ([@B43]). *Celastrus orbiculatus* Thunb. accelerated the hepatic cholesterol excretion in guinea pigs through suppressing oxidative stress *via* upregulation of the mRNA abundance of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoAR) and CYP7A1 ([@B119]). Glycyrrhizin (extracted from Glycyrrhizae Radix Et Rhizoma) modulated serum bile acid metabolism in MCD diet-fed mice by restoring inflammation-mediated hepatic farnesoid X receptor (FXR) inhibition ([@B106]). The modulation of herbal medicine on lipid and cholesterol absorption and transport involved the bile acid regulation and shows its beneficial effects on treating NAFLD.

Above all, we provided an important lipid mechanistic insight into the anti-NAFLD effects of herbal medicine, which was shown in [**Figure 1**](#f1){ref-type="fig"}. The commonly used herbal medicine inhibited fatty acid or diet-induced lipogenesis *via* SREBP-1c pathway and promoted the lipolysis focusing on fatty acid β-oxidation, which involved oxidative stress and mitochondrial function. The underlying mechanism of action might be achieved through the modulation of AMPK signaling pathway ([@B21]).

![The lipid mechanistic insight into the anti-NAFLD effects of herbal medicine. NAFLD, Non-alcoholic fatty liver disease.](fphar-11-00601-g001){#f1}

Herbal Medicine Ameliorates the Hepatic Inflammation {#s2_2}
----------------------------------------------------

Hepatic inflammation promotes lipid deposition and redistribution from adipose to liver and drives liver inflammatory injury. Hepatic inflammation triggers the development of NAFLD from hepatic steatosis to steatohepatitis and fibrosis ([@B74]). Amelioration of heaptic inflammation is vital for NAFLD therapy. It has been indicated that herbal medicine has exerted the protective effects against the progression from hepatic steatosis to steatohepatitis and the underlying mechanism have been proved to be involved in inhibiting the inflammatory signaling pathway as shown in [**Figure 2**](#f2){ref-type="fig"}, thereby regulating dyslipidemia and improving liver function in NAFLD. Many herbal medicine (including herbal formula, crude extract and pure bioactive compound form medicinal plants) possessed anti-inflammatory properties for slowing down the NAFLD progression, such as Sinai san dection ([@B118]), Hugan Qingzhi tablet ([@B93]), betulinic acid ([@B47]), *Alisma orientalis* ([@B15]), gastrodin ([@B2]), the peel extract of *Citrus aurantium L*. (Rutaceae) ([@B31]) and swertiamarin ([@B109]), and all of these medicine reduces the expression levels of hepatic inflammatory cytokines (TNFα, IL-6, and IL1β). Baicalin (extracted from *Scutellaria baicalensis* Georgi) ([@B123]) and aqueous extract of *Salvia miltiorrhiza* Bunge ([@B37]) show the anti-inflammatory action, further improve liver fibrosis by inhibition of α-SMA, Col1A1, and TGF-β1 production.

![The inflammatory mechanistic insight into the anti-NAFLD effects of herbal medicine. NAFLD, Non-alcoholic fatty liver disease.](fphar-11-00601-g002){#f2}

### NF-κB Pathway Involves in Herbal Medicine Modulation of Hepatic Inflammation {#s2_2_1}

We found out that the NF-κB signaling mentioned frequently in the anti-inflammatory response of herbal medicine in treating NAFLD. Jianpi Huoxue formula ([@B26]), baicalin ([@B123]) and *Lycium barbarum* polysaccharides showed ameliorative effects on hepatic inflammatory response involved with the reduction in Monocyte Chemotactic Protein-1 (MCP-1) expression, macrophage influx and hepatocyte apoptosis, partially owing to its power to suppress nuclear factor-κB (NF-κB) activation and the autophagic process of cleaved caspase-3 ([@B104]; [@B117]). Moreover, as a necessary prerequisite for triggering other inflammasome, the NF-κB signaling medicated the regulation of other inflammasome including NLRP3, the toll-like receptors and apoptosis mediators, all of which has been proved to be involved in the anti-inflammatory research of herbal medicine for NAFLD. Firstly, the palmitate acid-induced hepatocytes steatosis involved the activation of NLRP3 inflammasome and increased secretion of IL-1β and IL-18. And the NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) activation can be reversed by nobiletin and andrographolide (extracted from *Andrographis paniculata* (burm.f.)Nees) ([@B10]), as described by the downregulation of Caspase1, IL1β and IL18 expression *via* a NF-κB-dependent mechanism ([@B4]). Secondly, TLRs initiated signaling by binding to Myeloid Differentiation primary-response protein 88 (MyD88) triggers recruitment of TRAF6, TAK1, and MKK, which thereby activated the downstream signaling pathway of the extracellular signal-regulated kinase (ERK), p38MAPK, and c-jun N-terminal kinase (JNK). This activity leads to NF-κB nuclear translocation and the induction of gene transcription mediated by proinflammatory cytokines and chemokines. Toll-like receptors (TLRs) signaling pathways have been proved to participate in the anti-inflammatory response of herbal medicine in treating NAFLD. BuShenKangShuai tablet improved liver adiponectin resistance *via* inhibiting TLR4/NF-κB p65 signaling pathway, followed by the inhibition of TNF-α, IL-1β, MCP-1 and Vascular Vell Adhesion Molecule-1(VCAM-1), as well as the promotion of interleukin-10 and adiponectin production ([@B78]). Sparstolonin B (derived from *Sparganium stoloniferum* Buch.-Ham.) attenuated liver fibrosis through antagonizing TLR4 induced TGF-β signaling. Sparstolonin B augmented the hepatic TGFβ pseudo-receptor expression in mice, leading to downregulation of extracellular matrix deposition and hepatic stellate cell activation ([@B19]). Moreover, Sparstolonin B obviously inhibited Kupffer cell activities as evidenced by the decrease in MCP-1 and CD68 levels with concomitant suppression of macrophage infiltration *via* blocking NADPH oxidase-driven TLR4 trafficking to the lipid rafts in NASH ([@B18]). Dioscin rehabilitated inflammation ([@B65]) that was associated with the decreased expression levels of p50, p65, and IκBα *via* regulation of MyD88-dependent TLR4 signaling pathway ([@B122]; [@B107]). Garlic-derived S-allylmercaptocysteine mitigated NAFLD-induced inflammation *via* the restoration of the phosphorylated FFAs-dependent mitogen-activated protein kinases (MAPKs) and diminishment of the AP-1 and NF-κB activation ([@B102]). Berberine prevent NASH-derived hepatocellular carcinoma in mice *via* suppressing the phosphorylation of p38MAPK, ERK and COX2 expression ([@B73]).

### Apoptosis Signaling Involves in Herbal Medicine Modulation of Hepatic Inflammation {#s2_2_2}

The interference with the TLR mediated inflammatory response has proved to be involved into intracellular apoptosis signaling. These have been supported by the evidence that total aralosides from *aralia elata* (Miq) seem protected mice against HFD-induced cellular apoptosis, as suggested by TUNEL staining, and ameliorated NASH by inhibiting the NF-κB/IRE1α/JNK/IκB activation in ApoE^-/-^ mice ([@B72]); *Lycium barbarum* polysaccharides partially modulated hepatocyte apoptosis process *via* NF-κB/MAPK pathways, which has been proved to be related to the biological activity of l-arabinose and β-carotene in polysaccharides ([@B104]). Resveratrol and Sparstolonin B exerted a promising role on the modulation of cell proliferation and apoptosis *via* TLR4/phosphatidylinositol 3-kinase- (PI3K-)/AKT signaling pathway ([@B18]). *Psoralea corylifolia* L. inhibited NF-κB activation in the portal area to alleviate inflammatory cell infiltration and fibroplasia, further enhanced PI3K/Akt signaling to reduce hepatic superoxide anion expression, and NADPH oxidase activity as well as p47(phox) protein level and PKCα activation ([@B125]). Since the apoptosis signaling involves in herbal medicine modulation of hepatic inflammation, herbal medicine reduces the apoptotic cytokines such as caspases and Bcl-2 family proteins expression in the progression of hepatic inflammation. For instance, dioscin increased Bcl-2 production and blocked the activation of Bak, Caspase-3/9, FasL, Fas, p53 proteins *via* reducing IRF9 production against apoptosis ([@B65]; [@B88]; [@B122]). Polygonati Rhizoma could notably remedy mitochondrial apoptosis and alleviate HFD-induced NAFLD *via* increasing the expression levels of caspase 3, caspase 9, and Bax, while decreasing the Bcl-2 level in hepatocytes and cytchrome C in mitochondria ([@B108]). Furthermore, herbal medicine showed an effective role in inhibition of apoptotic cytokines, partially involved in the JNK-induced hepatocyte apoptosis for the treatment of NAFLD/NASH. Jianpi Huoxue formula (mainly consists of Atractylodis macrocephalae Rhizoma, Salvia miltiorrhizae Radix Et Rhizoma, Paeonia Radix Alba, Alismatis Rhizoma, and Schisandrae Chinensis Fructus) may have beneficial effects on MCD induced liver inflammation and apoptosis *via* the inhibition of the JNK phosphorylation and the activation of caspase 3 and 7 proteins ([@B26]). The ethyl acetate extract of *Aristolochia manshuriensis* Kom inhibited hepatic apoptosis *via* the suppression of ERK1/2 and JNK1/2 phosphorylation ([@B49]); Silibinin (a flavonolignan from milk thistle) ameliorated various symptoms of NASH by activating death domain-like apoptosis regulator (CFLAR)-JNK pathway, and thereby modulated its downstream target genes to promote the fatty acid β-oxidation (PPARα, SREBP-1C, and PNPLA3), anti-oxidase action (CAT, HO-1, and GSH-Px) and inhibition of pro-oxidase action (NRF2, CYP4A, and CYP2E1) to ameliorate oxidative stress, as well as inflammatory response ([@B97]; [@B66]; [@B70]). Therefore, activated hepatic apoptosis exerted a wide range of biological actions involved facilitating inflammation with oxidative stress modulation. And combined with the beneficial effects on liver steatosis, herbal medicine also relived the reliable growth in indicators of hepatocyte cytokine proinflammatory status, apoptosis, and fibrosis in the development of steatohepatitis.

### Autophagy Involves in Herbal Medicine Modulation of Hepatic Inflammation {#s2_2_3}

The lysosomal-mediated degradation process of autophagy is beneficial for removing the damaged cellular proteins and organelles, including mitochondria, peroxisomes, and endoplasmic reticulum (ER), thus the autophagy activation takes metabolic intermediates necessary for protein metabolism. And herbal medicine induced autophagy had been considered as an anti-inflammatory strategy to show the obvious effects on reducing the NAFLD progression. Resveratrol promoted the autophagy pathway to restore liver injury, which was linked with NF-κB activation ([@B42]); *Lycium barbarum* polysaccharides showed ameliorative effects on autophagic proteins (LC3II and Atg5), and deceased autophagic negative modulators (p62 and p-mTOR) *via* the NF-κB/MAPK pathways ([@B104]). Herbal medicine rehabilitated inflammation, reduced apoptosis and enhanced autophagy through both extrinsic and intrinsic apoptotic pathways, thereby counteracting the effects of NAFLD. For example, Dioscin inhibits collagen synthesis through modulating the expressions of autophagic flux (P62 LC-I LC-II) ([@B105]). Administration of Akebia saponin D (extracts from *Akebia quinata*) resulted in the upregulation of autophagic flux (e.g., decreased P62 accumulation and increased the level of LC3-II expression) in the liver of ob/ob mice ([@B29]); Glycycoumarin (a coumarin compound isolated from Rhizoma Glycyrrhizae) inhibited hepatocyte lipo-apoptosis through reactivation of impaired autophagy and inactivation of GSK-3. In line with autophagy activation, mitochondrial apoptotic activation, and ER stress-mediated JNK pathway were also blocked by glycycoumarin ([@B121]); Nobiletin ([@B116]), ginsenoside Rb2 (extracted from *Panax Ginseng* C.A.Mey) and Tangshen formula ([@B99]), could reverse the repression of autophagic pathways in AMPK-SIRT1 dependent manner ([@B41]). The AMPK/SIRT1 pathway mediated the activation of fork head box transcription factors that increased Atg proteins production, additionally, SIRT1 could combine with Atgs (Atg7 and Atg8) to form a molecular complex to deacetylate the core autophagy machinery. Resveratrol (a pharmacological SIRT1 activator) significantly prevented hepatocyte ballooning and steatosis, along with the changed levels of LC3-II, Beclin 1, and P62, as well as ER stress ([@B20]). It could be confirmed that resveratrol potentiated SIRT1 secretion and its deacetylase activity, which decreased p53 and increased autophagy. Further studies demonstrated that the effect of resveratrol on hepatic steatosis was achieved partially *via* the cAMP-PRKA-AMPK-SIRT1 autophagy pathway ([@B120]). Meanwhile, mTOR, another famous negative autophagic regulator, was decreased after some herbal treatments, such as Garlic-derived S-allylmercaptocysteine enhanced the levels of autophagic markers expression in the liver, with a concomitant decrease the mTOR activity ([@B103]).

Herbal Medicine Triggers Other Pathways in NAFLD {#s2_3}
------------------------------------------------

### Endoplasmic Reticulum (ER) Stress {#s2_3_1}

ER stress involved the increase of JNK and caspase-12 expression serves a primary role in the procession of NAFLD and pathogenesis to NASH. The pharmacological activation of FXR induced by betulinic acid alleviated the hepatic ER stress-mediated hepatic steatosis ([@B30]). The farnesoid X receptor (FXR) activation suppresses the expression of ER stress markers (PERK, EIF2α and ATF4) and CHOP signaling, thereby reducing hepatocellular ER stress. Betulinic acid could serve as an FXR agonist that effectively attenuates the pathogenesis of HFD and MCD induced NAFLD, and *Alisma orientalis* could restore the hepatocellular ER homeostasis by stimulating the FXR activation, particularly, Alisol A 24 (B 23)-acetate accounts for this action ([@B15]).

### Insulin Signaling Pathway {#s2_3_2}

Insulin-induced insulin receptor phosphorylation recruited the insulin receptor substrate-1 (IRS-1) and subsequently activated phosphoinositide 3-kinase (PI3K)/AKT pathway, leading to the activation of PKA and SGK-3β and ultimately encouraging glycogen and lipolysis synthesis, and subduing gluconeogenesis and lipogenesis ([@B50]). Naringenin ([@B76]), Ginsenoside Rb1([@B114]) and *Leonurus japonicus* Houtt extract ([@B51]) prevented hyperinsulinemia, leading to the correction of NAFLD associated metabolic disturbance that was linked to glucose utilization and insulin sensitivity ([@B51]). It has been found that nobiletin ([@B45]) and ursolic acid ([@B53]) ameliorated insulin resistance and takes effects on amplifying glucose uptake through IRS-1/AKT stimulation ([@B116]) in treatment of NAFLD; Jwa Kum Whan ameliorated insulin resistance and reduced hepatic triglyceride and cholesterol accumulation *via* significant triggered the phosphorylation of IRS-1 and PI3K ([@B59]). The potential underlying mechanism of Erchen decoction for the treatment of obesity, hyperlipidemia and fatty liver is to increase the CDKAL1 production, improve islet cell function and insulin level ([@B27]). A related study indicated that yangonin increased insulin sensitivity *via* increasing the expression of phosphorylated IRS-1 and IRS-2 ([@B22]).

Herbal Medicine Induced Gut Microbiota Alteration in NAFLD {#s2_4}
----------------------------------------------------------

It has been suggested that gut dysbiosis in patients have different shift in the development of NAFLD. There is an inverse association between the presence of NAFLD and the abundance of *Bacteroidetes* in gut microbiota, indicating that the intestine microbiota takes a vital role in the progression of NAFLD ([@B75]). Therefore, the modulation of intestine microbiota has become a potential therapeutic strategy for the treatment of NAFLD. Supplementation of prebiotic, probiotic compounds, or herbal medicine ([@B81]), have taken a modulatory effect on the intestine microbiota. Lingguizhugan decoction reduced hepatic steatosis and improved glycemic control through the modulation of gut microbiota ([@B68]). Microbiome analysis revealed that herbal formula shenling baizhu powder promoted the relative percentage of short-chain fatty acid-producing microbiota, such as *Bifidobacterium* and *Anaerostipes* ([@B124]). Mechanistic studies found that herbal formula such as shenling baizhu powder alleviated hepatic steatosis and repaired colon mucosa *via* decreasing the expression level of endotoxin and inflammatory mediators (TNF-α, IL-1β) *via* the TLR4 pathway ([@B124]). Diammonium glycyrrhizinate is a medicinal form of glycyrrhizic acid and has been proved to modify gut microbiota composition to decrease the intestinal low-grade inflammation and restore intestinal barrier function in NAFLD mice. Diammonium glycyrrhizinate reduced the abundance of the endotoxin-producing bacteria such as *Desulfovibrio* and elevates the level of probiotics such as *Lactobacillus* and *Proteobacteria*, as well as augmented the abundance of short-chain fatty acid (SCFA)-producing bacteria such as *Ruminococcaceae* and *Lachnospiraceae* to promote SCFA production ([@B57]).

Clinical Application of Herbal Medicine on NAFLD {#s2_5}
------------------------------------------------

In the clinical setting, clinical trials could confirm the experimental benefits of herbal medicine application in NAFLD patients. Clinical trials for NAFLD have been seen improvement with herbal medicine therapy. Randomized controlled trials comparing either herbal medicine alone or in combination with other interventions or pharmaceutical agents have been investigated and the results indicated that herbal medicine had a better effect on the normalization of AST and the disappearance of radiological steatosis in the treatment of NAFLD patients ([@B89]). For instance, the daily consumption of resveratrol plus with lifestyle modification for 12 weeks showed superior effect than lifestyle change alone. Meanwhile, after resveratrol supplementation, the decreased level of insulin resistance, ALT, AST, LDLC, TC, and TNF-α were showed in NAFLD patients ([@B6]). It is essential to prove the efficacy and safety of herb medicine in treating NAFLD, because the side-effects of herb medicine need to be confirmed and investigated further ([@B84]) in clinical application. Because some herbal medicines such as *Phyllanthus urinaria* L. that has been suggested as the hepatoprotective herb in animal studies showed unsatisfactory effect in improving NAFLD activity score in NASH patients ([@B101]). The development of Radom Control Trials for herbal medicine is important and essential for making validation about the efficacy of herbal medicine in treating NAFLD. We made summery about the clinical trials about the effective herbal medicine (including herbal formula, crude extract and pure bioactive compound form medicinal plants) that have proved to take positive effects on the biochemical and physiological features of NAFLD ([@B63]).

### Herbal Formula Against NAFLD {#s2_5_1}

According to Chinese Medicine theory and prescription principles, the herbal formula is developed with selection of appropriate medicinal plants and the dosage of each herb for treating patients with NAFLD. The meta-analysis of 62 randomized controlled trial was conducted to investigate the herbal medicine therapy for NAFLD. It indicated that 246 Chinese herbs have been found to be included and clinical applied for NAFLD with an average of ten species in each formulation. It was found out that herbal medicine take effective action on the therapy of NAFLD, and Crataegi Fructus (Shan-Zha) was the most common used herbal medicine for 321 times in 17,670 patients ([@B89]). Many herbal formulas have been reported to show anti-NAFLD function in clinical application. For example, Yinchenhao Decoction has been used in treatment of gallbladder and liver diseases for centuries and it was composed of *Artemisia capillaris* (Thunb), *Gardenia jasminoides* (Ellis), and *Rheum palmatum* (L) ([@B111]); Oral administration of Danning Tablet (composed of Rhei Radix Et Rhizoma, Polygoni Cuspidati Rhizoma Et Radix, dried green orange peel and dried old orange peel) for three month in 232 patients can improve the clinical symptoms of NAFLD ([@B23]); The results of meta-analysis showed that HuoXueHuaYu improved B ultrasonic level in patients with NAFLD. As to lipids, HuoXueHuaYu showed effective action on reduction of TC, TG, ALT, and AST levels ([@B11]); Bangpungtongseong-san is an ancient Chinese herbal medicine formula and has been clinically applied in Korea, Japan (Bofu-tsusho-san), and China (Fang feng tong sheng-san) for obesity and its associated metabolic syndrome ([@B48]); Erchen Decoction is used for the treatment of obesity, hyperlipidemia, and fatty liver diseases. Seven randomized controlled trials with a total of 1951 participants were investigated for the effects of Erchen Decoction on patients with NAFLD. The meta-analysis results of Erchen Decoction investigation showed that patients receiving Erchen Decoction with conventional treatment showed more effective in clinical improvement of NAFLD compared with conventional treatment alone ([@B56]); The Dava AL-balgham (composed of *Nigella Sativa*, *Zataria Multiflora*, *Trachyspermum ammi*, *Pistacia lentiscus* have shown anti-inflammatory, anti-atherogenic, and anti-oxidant effects. A double blind randomized trial of Dava AL-balgham has been applied for 76 patients with fatty liver disease. After three month treatment, Dava AL-balgham could improve the serum level of liver enzymes in patients with fatty liver ([@B38]).

### Single Herb Against NAFLD {#s2_5_2}

The meta-analysis was performed to confirm the efficiency and safety of *Salvia miltiorrhiza* Bunge (Danshen) in eight randomized controlled trials with 800 patients. It indicated that *Salvia miltiorrhiza* Bunge showed positive effects on the levels of ALT, AST, TC and TG, LDL, and liver/spleen computed tomography ratio in patients with NAFLD. Future randomized clinical trials of higher quality are still required to evaluate the efficacy and safety of *Salvia miltiorrhiza* Bunge in NAFLD ([@B80]). *Panax Ginseng* C.A.Mey has been often applied against multiple metabolic conditions, including hepato-steatosis, Korean Red Ginseng shows anti-inflammatory and anti-fatigue effects on 80 patients with NAFLD ([@B36]).

### Pure Natural Compound Against NAFLD {#s2_5_3}

Curcumin (a natural polyphenol from *Curcuma longa* L.) owed the lipid-modifying, anti-inflammatory and antioxidant properties. Panahi et al. reported a randomized placebo controlled trial of curcumin in 87 subjects with NAFLD ([@B77]) and concluded that daily supplementation of curcumin for 8 weeks decreased liver lipid accumulation and the levels of AST and ALT in patients of NAFLD without any issues of tolerance ([@B67]). Diammonium glycyrrhizinate, a medicinal form of glycyrrhizic acid possesses anti-inflammatory and antioxidant effects. It has been applied for the treatment and control of chronic hepatopathy including NAFLD([@B57]); Cinnamon ([@B8]) showed the improvement of the serum glucose and lipid levels in people with non-insulin dependent type 2 diabetes mellitus (NCT00237640). Further studies with 50 patients NAFLD were tested to investigate whether Cinnamon exerts the insulin sensitizer action in NAFLD patients. The results showed that daily intake of Cinnamon (1.5 g) for 12 weeks has beneficial effects on lipid profile, insulin resistance, liver enzymes, and high-sensitivity C-reactive protein in NAFLD patients ([@B4]). Ginger possess strong antioxidant ability to reduce lipids peroxidation ([@B90]). The Early Phase I clinical investigation of Ginger in treatment of NAFLD in patients with type 2 diabetes mellitus (NCT02289235) is in progress to test whether Ginger takes effects on the liver biomarkers (ALT, AST, and γ-glutamyl transpeptidase) and fatty liver score in fibro-scan. A multi-center, phase III, double-blind clinical trial reported that oral administration of silybin combined with phosphatidylcholine and vitamin E for 12 months can improve insulin resistance, liver enzymes, and liver histology ([@B71]). The clinical trial study of Silymarin (IRCT201202159018N1) was conducted on 64 patients with NASH and after 8 weeks treatment, the patients with NASH experience obvious fall in hepatic enzymes ([@B91]).

### Others {#s2_5_4}

At present, the clinical trials recorded in U.S. National Library of Medicine mentioned the herbal medicine in treating NAFLD includes YiQiSanJu formula (NCT01677325, Phase I completed), Phyllanthus urinaria (NCT01210989, N/A completed), Zhenzhu Tiaozhi capsules (NCT03375580, N/A Recruiting), Fermented ginseng powder (NCT03260543, N/A completed), Trigonella Foenum-graecum Seed Extract (NCT02303314, Phase II, and III completed), *Zataria Multiflora* Boiss. (Shirazi's thyme) (NCT02983669, N/A completed), and Ginger (NCT02535195, Phase II and III completed), as well as some bioactive natural compounds such as Berberine (NCT04049396, NCT03198572 Recruiting, Phase IV), Curcumin (NCT03864783, Recruiting), Silymarin (NCT02006498, Phase II completed and NCT02973295, Phase IV Recruiting), Resveratrol (NCT02030977, Phase II and III completed; NCT01464801, N/A completed; NCT01446276 N/A completed), Anthocyanin (NCT01940263, Early Phase I completed), Pioglitazone and Berberine (NCT00633282, phase II Completed), Anthocyanin (NCT01940263, phase II Completed) and Siliphos (NCT00443079, phase II Completed).

Conclusion and Discussion {#s2_6}
-------------------------

Following the general requirement of the pharmacological research of herbal medicine ([@B32]), we firstly made assessment of the pharmacological research literature on herbal medicine, focusing on the experiment design, we checked the methodological details such as group size, controls and animal species. Specifically, we observed the dosage, route and frequency of drug administration in the research literature, and checked the tested dose range that should be pharmacological relevant. After the assessment, the literature of herbal medicine that reach the general requirement of the pharmacological research are included in our review. As shown in [**Table 1**](#T1){ref-type="table"}, a large number of natural compounds, whole extract and herb formula have been widely investigated against different pathologies of NAFLD with promising results ([@B82]). Increasing evidence has shown polyphenols ([@B82]) including resveratrol ([@B1]), quercetin (green tea, soy isoflavones) silymarin (extracted from *Sylbum marianum*), silybin and rutin ([@B94]) are the frequently investigated natural compounds, along with the satisfactory effectiveness in NAFLD. As shown in [**Figure 3**](#f3){ref-type="fig"}, herbal medicine mediated the key pathological events in the procession of NAFLD include lipid metabolism dysfunction, insulin resistance, fibrosis, oxidative stress, inflammation, and apoptosis ([@B96]). The satisfactory improvement of NAFLD disease outcomes and endpoints mentioned the amelioration or reduction of fat mass, insulin resistance, serum level of FFA, AST, and ALT, hepatic lipid accumulation and fibrosis, as well as hepatic oxidative stress, inflammatory response, and apoptosis. Thus, we made a review of the usage and role of herbal medicine in NAFLD. Steatosis, characterized by fat accumulation, represented the early stage of NAFLD and inflammation that interfered with the insulin signaling pathway is the key process that makes early steatosis develop into steatohepatitis ([@B5]). Therefore, amelioration of steatosis and inflammation is vital for NAFLD therapy. Herbal medicine therapy has shown promising anti-inflammatory, antioxidant, and anti-apoptotic properties that might take beneficial effects on curtailing the inflammatory progression of NAFLD. Their action was always involved in multi-pathways to improved NAFLD, such as baicalin exerted anti-inflammation and anti-oxidant effects that can reduce hepatic lipid accumulation, suppress induced hepatic inflammation, and prevent liver fibrosis involved inhibiting hepatocyte apoptosis ([@B123]). Gegenqinlian decoction influence NAFLD *via* improving PPARγ to inhibit inflammation and modulated lipid metabolism ([@B95]). *Alisma orientalis* protected against *de novo* lipogenesis to upregulate hepatic lipid export. Additionally, it modulated oxidative stress cytokines, inflammatory and fibrotic mediators, eventually influenced lipo-apoptosis and liver injury panels ([@B15]). Resveratrol can be considered as a pharmacological SIRT1 activator ([@B120]) and take effects on hepatic steatosis by improving lipid-related gene transcriptional expression, oxidative stress and inflammation ([@B14]), meanwhile decreasing ER stress ([@B20]) *via* the autophagy ([@B64]). In addition, it has shown that herbal medicine combined with other interventions exhibited a much better beneficial effect than single interference alone. For example, Lingguizhugan decoction and calorie-restriction therapy together could enhance the reduction of fasting blood lipid levels ([@B115]; [@B12]). The combination of Korean red ginseng and probiotic *Lactobacillus* synergistically ameliorated hepatic inflammation ([@B46]). The combination of Ganmaidazao and Shengmai-Yin decoction is applied as adjuvant therapy for Type II diabetes mellitus *via* activation of HSL, PPARα, and AMPK/PI3K/AKT, and inhibition of SREBP-1/FAS, influencing insulin sensitivity, and lipid biosynthesis ([@B58]). Two types of anti-dyslipidemia herb formulas (Fenofibrate and xuezhikang) have been simultaneously applied in the treatment of NAFLD ([@B34]) as well as combined use of *Fructus Schisandrae* with statin showed anti-oxidative effect and inhibitory effect against liver toxicity ([@B100]). *Schisandra chinensis* Baill has been used as a complementary therapy for rosiglitazone and alleviated NASH with significantly lower levels of LDLC and SOD in liver than rosiglitazone ([@B110]; [@B100]). Therefore, herbal medicine supplement combined with other therapeutic approaches might provide feasible therapeutic strategies for patients with NAFLD ([@B82]).

###### 

The recent research for herb medicine in the setting of NAFLD therapy.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Herbal Medicine                                  Source organism                                                                                                                                                                                                                                                                                                                                               Pharmacological model                                 Treatment (Pharmacological model and Duration)   Effective Dosage                   Reported mechanism of action                                                                                 
  ------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------- ------------------------------------------------ ---------------------------------- ------------------------------------------------------------------------ ----------------------------------- ------------------------------------------------------------------------
  S-allylmercaptocysteine                          Garlic-derived                                                                                                                                                                                                                                                                                                                                                HFD induced obese rat                                 i.p, 3 times/week                                200 mg/kg                          ↓                                                                        ↓NF-κB and AP-1                     ↓Collagen formation ↓Oxidative stress ↑Autophagy

  Dioscin                                          Polygonati Rhizoma                                                                                                                                                                                                                                                                                                                                            HFD induced obese rats                                Orally,                                          60 mg/kg                                                                                                    ↓ IκBα, p50 and p65                 ↓Collagen formation

  HFD induced obese Wistar rats and mice           Orally, 8 weeks                                                                                                                                                                                                                                                                                                                                               15--80mg/kg                                           ↑SIRT1/AMPK                                      ↓**Apoptosis**                                                                                                                                  

                                                                                                                                                                                                                                                                                                                                                                                                                 Dimethylnitrosamine-induced acute liver injury mice   Orally,                                          80 mg/kg                           ↓LXRα                                                                    ↓                                   ↓**Oxidative stress(**↑SIRT1, Nrf2)

  Resveratrol                                                                                                                                                                                                                                                                                                                                                                                                    MCD diet induced NAFLD mice                           Orally,                                          100 or 250 mg/kg/day                                                                                        ↓TBARS                              ↑**Autophagy**

                                                                                                                                                                                                                                                                                                                                                                                                                 AML12 cells                                                                                            25, 50, or 100 μmol/L              ↓ FFA uptake.                                                                                                

                                                                                                                                                                                                                                                                                                                                                                                                                 C57BL/6J mice and as ULK1+/− mice with HFD            Orally, 4 weeks.                                 50 mg/kg                                                                                                    ↓ IκBα-NF-κB                        ↓ **Oxidative stress**

  ↓Fibrosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

                                                                                                                                                                                                                                                                                                                                                                                                                 Mice with HFD for 4 weeks                             Orally, 4 weeks.                                 0.40%                                                                                                                                           ↓**Oxidative stress**

                                                                                                                                                                                                                                                                                                                                                                                                                 HepG2 cells                                           24 h                                             20, 40, and 80μM                                                                                                                                

                                                                                                                                                                                                                                                                                                                                                                                                                 Wistar rats with HFD                                  Orally, 18 weeks                                 200 mg/kg                                                                                                   ↑ cAMP-PRKA-AMPK-SIRT1              ↓ ER stress(↑SIRT1)

  Naringenin                                       Citrus-derived flavonoid                                                                                                                                                                                                                                                                                                                                      LDLR−/− mice with HFD                                 Orally, 4 weeks                                  1% or 3% wt/wt                     ↓ VLDL                                                                                                       ↑ insulin resistance

  Yangonin                                         Piper methysticum                                                                                                                                                                                                                                                                                                                                             Mouse fed with HFD                                    Orally, 16 weeks                                 10, 20, or 40 mg/kg                ↓SREBP-1c pathway;↑ fatty acid β-oxidation                                                                   ↑insulin sensitivity

  ↓Fibrosis (↑ FXR)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Berberine                                        Coptidis Rhizoma                                                                                                                                                                                                                                                                                                                                              Mice fed with HFD                                     Orally; for 4 weeks                              300 mg/kg/day                      ↓ SCD1 *via* AMPK-SREBP-1c pathway                                       p38MAPK/ERK-COX2 pathways           ↓Fibrosis

                                                                                                                                                                                                                                                                                                                                                                                                                 AML12                                                                                                  20 μM                                                                                                                                           

                                                                                                                                                                                                                                                                                                                                                                                                                 NASH-HCC mice model                                   Orally, 12 week                                  250 mg/kg                                                                                                                                       

  Betulinic acid                                   Outer bark of tree species                                                                                                                                                                                                                                                                                                                                    Mice fed with HFD                                     Orally, 11 weeks                                 50 mg/kg,                          ↓ SREBP-1c, ApoC2, RBP4, FAS, and SCD- 1; ↑AMPK ↑ fatty acid oxidation   ↓F4/80, IL-1α, IL-1β, IL-6, TNF-α   ↓Fibrosis (↑ FXR)

                                                                                                                                                                                                                                                                                                                                                                                                                 AML12 treated with palmitic acid (PA)                                                                  50 μg/ml                                                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                 Mice fed with MCD and HFD                             Orally, 6 weeks                                  100 mg/100 g diet                                                                                                                               

  Glycyrrhizin                                     Glycyrrhizae Radix Et Rhizoma                                                                                                                                                                                                                                                                                                                                 Mice fed with MCD diet                                i.p, 2 weeks                                     50 mg/kg per day                   ↓ lipogensis                                                             ↓NLRP3                              

  ↑FXR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  Gastrodin                                        *Gastrodia elata* Bl                                                                                                                                                                                                                                                                                                                                          Larval zebrafish fed with HFD                                                                          10, 25, 50 mg/L                    ↓ lipogensis                                                             ↓TNFα, IL-6, and IL1β               ↓Fibrosis ↓TGFβ1)

  **Oxidative stress** ↑NRF2, HO-1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Naringenin                                       Citrus-derived flavonoid                                                                                                                                                                                                                                                                                                                                      *Ldlr*−/− mice fed a Western diet                     Orally, 4 weeks                                  1 or 3%                            ↓ SREBP1c;\                                                                                                  ↓ hyperinsulinemia
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           ↓VLDL;↑ fatty acid oxidation                                                                                 

  Puerarin                                         *Pueraria lobate* (Willd.)Ohwi                                                                                                                                                                                                                                                                                                                                Mice fed with a high-fat +high-sucrose diet           Orally, 18 weeks                                 0.2,0.4g/kg/day                    ↓liver steatosis                                                         ↓                                   ↓Fibrosis ↓TGFβ1)

  Silibinin                                        *Silybum martanum* (L.) Gaertn.                                                                                                                                                                                                                                                                                                                               MCD diet induced NASH mice                            Orally, 6 weeks                                  10 and 20 mg/kg/day                ↑ β-oxidation                                                            ↓NASH *via* CFLAR-JNK pathway,      **Oxidative stress** ↑CAT, GSH-Px and HO-1; ↓CYP2E1, CYP4A

                                                                                                                                                                                                                                                                                                                                                                                                                 NCTC-1469 cells treated with OA plus PA                                                                50 and 100 μmol/L                                                                                                                               

                                                                                                                                                                                                                                                                                                                                                                                                                 HepG2 cells treated with OA                                                                            5, 20, 50, and 100 μM              ↓PPARα, SREBP-1C and PNPLA3                                              ↓NO                                 ↓glucose uptake (PI3K-AKT) ↓**oxidative stress** (NRF2, CYP2E1, CYP4A)

  Sparstolonin B                                   *Sparganium stoloniferum* Buch-Ham                                                                                                                                                                                                                                                                                                                            High-fat-fed mice                                     ip, for 4 week                                   3 mg/kg, twice a week              ↓TLR4 lipid raft trafficking                                             ↓ TLR4 pathway                      ↓Fibrosis ↓TGFβ1)

  ↓NADPH oxidase activation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

                                                                                                                                                                                                                                                                                                                                                                                                                 Kupffer cell line                                                                                      100 μg/ml                                                                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                                 LX2 cells with LPS (100 ng/ml)                                                                         10, 100 μM                                                                                                                                      

  Isochlorogenic acid B                            Laggera alata (Asteraceae)                                                                                                                                                                                                                                                                                                                                    Mice fed with MCD diet                                Orally, 4 weeks                                  5, 10 and 20 mg/kg.                                                                                                                             ↓Fibrosis (↓TGFβ1, LXO,MCP-1, COL1α1 and TIMP-1.)

  ↓ oxidative stress (↑Nrf2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Swertiamarin                                     Swertia bimaculata                                                                                                                                                                                                                                                                                                                                            Fructose-fed mice for 12 week                         Orally, 4 weeks                                  25, 50 and 100 mg/kg               ↓ SREBP-1/FAS/ACC                                                        ↓hepatic pro-inflammation           ↓ hepatic xanthine oxidase (XO) ↑Nrf2

  Baicalin                                         *Scutellaria baicalensis* Georgi                                                                                                                                                                                                                                                                                                                              MCD diet-induced NASH                                 Orally, 4weeks.                                  50 and 100,200 mg/kg               ↓                                                                        ↓ inflammation                      ↓Fibrosis ↓ hepatic apoptosis.

  Ursolic acid(UA)                                                                                                                                                                                                                                                                                                                                                                                               Mice fed with HFD                                     Orally, 16 week                                  0.05% (w/w) UA diet                                                                                                                             ↓Fibrosis

                                                                                                                                                                                                                                                                                                                                                                                                                 T090-induced mouse model.                             Orally, 7 days                                   100, 250 mg/kg/day                 Liver X Receptor α antagonist                                                                                

                                                                                                                                                                                                                                                                                                                                                                                                                 L02 cells treated with PA                                                                              10--30 μg/ml                       ↓ lipid accumulation                                                                                         ↓oxidative stress.

                                                                                                                                                                                                                                                                                                                                                                                                                 Rat fed with HFD                                      Orally, 6 weeks.                                 0.125%, 0.25%, 0.5% UA diet                                                                                 ↓ inflammation                      ↓ insulin resistance

  Andrographolide                                  *Andrographis paniculata* (Burm. f.)Nee                                                                                                                                                                                                                                                                                                                       Mice fed with CDAA diet                               i.p, 22 weeks                                    1 mg/kg, 3 times/week                                                                                       ↓hepatic inflammation               ↓collagen formation

                                                                                                                                                                                                                                                                                                                                                                                                                 Fat-laden HepG2 cells.                                                                                 50 μM                                                                                                       ↓ NF-κB                             

  Ginsenoside Rb1                                  *Panax Ginseng* C.A.Mey                                                                                                                                                                                                                                                                                                                                       Rat fed with HFD                                      ip                                               10 mg/kg                           ↑CPT1                                                                                                        

                                                                                                                                                                                                                                                                                                                                                                                                                 db/db mice                                            i.p, 14 days.                                    20 mg/kg                           ↓                                                                        ↓                                   

  Nobiletin                                        *Citrus reticulata* Blanco                                                                                                                                                                                                                                                                                                                                    Mice fed a high-fat diet                              Orally, 16 weeks.                                0.02%, w/w                                                                                                  ↓ NLRP3                             

                                                                                                                                                                                                                                                                                                                                                                                                                 High glucose induced hepG2 cells                                                                       5, 25, and 50 μM                   ↑AMPK                                                                                                        

  Ginsenoside Rb2                                  *Panax Ginseng* C.A.Mey                                                                                                                                                                                                                                                                                                                                       HepG2 cells                                                                                            50 µmol/L                                                                                                                                       ↑Autophagy

                                                                                                                                                                                                                                                                                                                                                                                                                 db/db mice                                            i.p, 4 weeks                                     10 mg/kg                           ↑AMPK or SIRT1                                                                                               

  Akebia saponin D                                 *Dipsacus asper* Wall.ex Henry                                                                                                                                                                                                                                                                                                                                ob/ob mice fed with HFD                               i.p, 4 weeks                                     30,60,120 mg/kg,                                                                                                                                **↑Autophagy**

                                                                                                                                                                                                                                                                                                                                                                                                                 OA stressed Buffalo rat liver cells                                                                    1, 10, and 100 μM                                                                                                                               ↑ LC3-II ↓P62

  Glycycoumarin                                    Rhizoma Glycyrrhizae                                                                                                                                                                                                                                                                                                                                          PA stressed cells (HepG2, AML-12, and L02)                                                             10--40μM                                                                                                                                        ↓Mitochondrial apoptosis(↓GSK-3,↓JNK)

                                                                                                                                                                                                                                                                                                                                                                                                                 MCD diet induced NASH mice                            i.p. 4 weeks                                     GCM 15 mg/kg/day                   ↓Lipogenesis                                                             ↓Inflammation                       ↓ Fibrosis; Oxidative stress

  ethanol extract                                  *Lycopus lucidus* Turcz. ex Benth                                                                                                                                                                                                                                                                                                                             HepG2 cells treated with OA plus PA                                                                    250--1000 mg/ml.                   ↑PPARα, AMPK ↓SREBP-1c                                                                                       

                                                                                                                                                                                                                                                                                                                                                                                                                 Mice fed with HFD                                     Orally,14 weeks.                                 100 or 200 mg/kg/day                                                                                        ↓TNF-α                              

  Danshen aqueous extract                          *Salviae miltiorrhiza* Bge.                                                                                                                                                                                                                                                                                                                                   Mice fed with ethanol                                 Orally, 9 days                                   0.093, 0.28, 0.84 g/kg             ↓Lipogenesis                                                             ↓Inflammation                       ↓ Fibrosis

  Jwa Kum Whan                                     Scutellariae Radix and Euodiae Fructus                                                                                                                                                                                                                                                                                                                        Mice fed with HFD                                     Orally, 15 week                                  100,200 mg/kg daily                                                                                                                             ↑Insulin Signaling

                                                                                                                                                                                                                                                                                                                                                                                                                 HepG2 cells                                                                                            10, 25, 50, 75, or 100 μg/ml                                                                                                                    

  Ethanol Extract                                  *Leonurus japonicus* Houtt.                                                                                                                                                                                                                                                                                                                                   Mice fed with HFD                                     Orally, 14 weeks                                 100 or 200 mg/kg                   ↑ AMPK, PPARα                                                                                                ↑Insulin Signaling

                                                                                                                                                                                                                                                                                                                                                                                                                 1 mM free fatty acid induced HepG2 cells                                                               250, 500, 750, or 1000 μg/ml       ↑ AMPK, PPARα                                                                                                

  honeyberry extract                               *Lonicera caerulea*                                                                                                                                                                                                                                                                                                                                           Mice fed with HFD                                     Orally, 6 weeks.                                 0.5%, 1%                           ↑ AMPK, CPT-1,PPARα                                                                                          

  polysaccharides                                  *Lycium barbarum* L.                                                                                                                                                                                                                                                                                                                                          Rat treated with HFD                                  Orally, 4 weeks                                  1 mg/kg,                           ↓lipid accumulation ↑ fatty acid oxidation                                                                   

  methanolic extract                               *Alisma orientale* (Sam.)Juzep.                                                                                                                                                                                                                                                                                                                               Rats fed with HFD for 6 weeks                         Orally, 6 week                                   150, 300, and 600 mg/kg            ↑AMPK, PPARα                                                             ↓Inflammation                       ↓apoptosis;↓ oxidative stress;↑insulin sensitive

  Seed Extract                                     *Psoralea corylifolia L*.                                                                                                                                                                                                                                                                                                                                     Mice fed a HFD                                        orally, 12 weeks                                 300 or 500 mg/g/d,                 ↓Lipogenesis                                                             ↓Inflammation                       ↑Insulin Signaling

  Extract                                          *Schisandra chinensis* (Turcz)Baill                                                                                                                                                                                                                                                                                                                           Wister rats fed with HFD                              56 days                                          100 mg/kg/day                      ↓ LDLC                                                                                                       ↓Endoplasmic reticulum (ER) stress

  Total saponins                                   *Aralia elata* Seem.                                                                                                                                                                                                                                                                                                                                          ApoE-/- mouse fed with HFD.                           i.g., 12 weeks.                                  75, 150 mg/kg/day                                                                                           ↓Inflammation                       **↓**oxidative stress.

  Total alkaloids                                  *Rubus aleaefolius* Poir.                                                                                                                                                                                                                                                                                                                                     HFD for 8 weeks                                       orally, 4 weeks                                  1.44, 0.72 g/kg                    ↓FAS, ACC ↑CPT                                                                                               

  Polygonatum kingianum                                                                                                                                                                                                                                                                                                                                                                                          Rat fed with HFD                                      Orally, 14 weeks                                 1, 2, 4g/kg                                                                                                                                     Remedy mitochondrial dysfunction

  Ethyl acetate extract                            *Aristolochia manshuriensis* Kom                                                                                                                                                                                                                                                                                                                              HFD-induced NASH model                                15 weeks                                         2.5 mg/kg                                                                                                   ↓Inflammation                       ↓oxidative stress.

  ↓apoptosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  Fructus Schisandrae                                                                                                                                                                                                                                                                                                                                                                                            SD rats fed with HFD for 8 weeks:                     orally, 8 weeks                                  0.45% FS+0.3% Atorvastatin                                                                                                                      ↓oxidative stress.

  Aqueous extract                                  *Salvia miltiorrhiza* Bunge                                                                                                                                                                                                                                                                                                                                   Ovariectomized (OVX)+ hyperlipidemic SD rats          Orally, 12 weeks                                 600 mg/kg/d                                                                                                                                     ↓ Fibrosis

  The chloroform extract                           *Cyclocarya paliurus*                                                                                                                                                                                                                                                                                                                                         SD rats fed with HFD for 6 weeks                      Orally, 4 weeks.                                                                                                                                                                                 ↓ Fibrosis

  Saponins Raw and processed                       *Panax Notoginseng* (Burk.) F.H.Chen                                                                                                                                                                                                                                                                                                                          *CCl*~4~ induced fibrosis in rat                      i.p                                              130 mg/kg                                                                                                   ↓Inflammation                       ↓ Fibrosis

  Citrus aurantium Peel Extract                    *Citrus aurantium* L. *(Rutaceae*)                                                                                                                                                                                                                                                                                                                            Mice fed with HFD                                     orally, 8 weeks                                  50, 100 mg/kg                      ↓PPAR-γ, SREBP-1c                                                        ↓ inflammation                      

  Korea red ginseng                                *Panax ginseng* C.A.Mey                                                                                                                                                                                                                                                                                                                                       Fatty Rats                                            orally, 2 months                                 200 mg/kg/day                                                                                               ↓ inflammation                      ↓oxidative stress.

  *Celastrus orbiculatus* Thunb.                                                                                                                                                                                                                                                                                                                                                                                 ApoE(-/-) mice                                        Orally, 6 weeks                                  10.0 g/kg/d                        ↑adiponectin                                                             ↓TLR4 and NF-κB p65, TNF-α.         

                                                                                                                                                                                                                                                                                                                                                                                                                 A guinea pig of NAFLD                                 Orally, 8 weeks                                                                     ↑CYP7A1 and HMGCR                                                                                            ↓NO and iNOS levels

  BaiHuJia RenShen Decoction                       Anemarrhenae Rhizoma, Gypsum Fibrosum, Glycyrrhizae Radix Et Rhizoma,Ginseng Radix Et Rhizoma                                                                                                                                                                                                                                                                 HuS-E/2 cell with PA                                                                                                                      ↑P-AMPK;P-ACC; ↓SCD1 ↑CPT                                                                                    

  db/db mice                                       orally, 6 weeks                                                                                                                                                                                                                                                                                                                                               900 mg/kg                                                                                                                                                                                                                                              

  BuShenKangShuai tablet                                                                                                                                                                                                                                                                                                                                                                                         ApoE (-/-) mice                                       Gavage, 6 weeks                                  BSKS or atorvastatin                                                                                        ↑adiponectin ↓TLR4 and NF-κB p65    

  LiGanShiLiuBaWei San                             Punica granatum, Cinnamomum cassia, Elettaria cardamomum, Piper longum, Carthamus tinctorius, Amomum tsao-ko                                                                                                                                                                                                                                                  Rat with HFD                                          Orally, 4 weeks                                  0.75 and 1.5 g/kg                  ↑PPARα                                                                                                       ↓iNOS levels

  HepG2 with FFAs                                                                                                                                                                                                                                                                                                                                                                                                                                                      ↑PPARβ                                                                                                                                                                                           

  Hugan Qingzhi tablet                             Alismatis Rhizoma, Crataegi Fructus, Typhae Pollen, Nelumbinis Folium, Notoginseng Radix Et Rhizoma                                                                                                                                                                                                                                                           L02 and HepG2 cells induced by FFA                                                                                                                                                                                 ↑SIRT1 ↓Ac-NF-κB-p65                

  Rat with HFD                                     Orally, 12 weeks                                                                                                                                                                                                                                                                                                                                              2.16/1.08/0.54 g/kg                                                                                                                                                                                                                                    

  Sinai san decoction                              Bupleuri Radix, Paeoniae Radix, Aurantii Fructus Immaturus, Glycyrrhizae Radix Et Rhizoma                                                                                                                                                                                                                                                                     Rat with HFD+CCL4                                     Orally, 8 weeks                                  0.1 ml/kg/day                                                                                               ↓ inflammation                      

  Gegenqinlian Decoction                           PuerariaeLobataeRadix, Coptidis Rhizoma, Scutellariae Radix, Glycyrrhizae Radix Et Rhizoma                                                                                                                                                                                                                                                                    Rat with HFD                                          Orally, 8 weeks                                  5.04, 10.08 g/kg/day               ↓PPARγ                                                                                                       

  Tangzhiqing Decoction                            Mori Folium, Nelumbinis, Crataegi Folium, Salviae Miltiorrhizae Radix Et Rhizoma, Paeoniae Radix Rubra                                                                                                                                                                                                                                                        Rat with HFD                                          Orally, 4 weeks                                  540 mg/kg/d                        ↓steatosis                                                                                                   

  Qushi Huayu Decoction                            Artemisiae scopaiae Herba, Polygoni cuspidati Rhizoma Et Radix, Hyperici Japonici Herba, Curcumae longae Rhizoma, Gardenia jasminoides Ellis                                                                                                                                                                                                                  Rat with HFD                                          Orally, 4 weeks                                  0.1 ml/kg·d,                       ↑AMPK and ACC                                                                                                

                                                                                                                                                                                                                                                                                                                                                                                                                 L02 cells                                                                                              5%--15% QHD serum                  ↓ cellular TG                                                                                                

  Hugan Qingzhi tablet                             Alismatis Rhizoma, Crataegi Fructus, Typhae Pollen, Nelumbinis Folium, Notoginseng Radix Et Rhizoma                                                                                                                                                                                                                                                           Rat with HFD                                          Orally,                                          10% HQT-medicated serum            ↓                                                                        ↓IL-6, ↓P65                         

  90 mg/kg, combination with calorie restriction                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Lingguizhugan decoction                          Poria, Ramulus Cinnamomi, Atractylodis Macrocephalae Rhizoma,Glycyrrhizae Radix Et Rhizoma                                                                                                                                                                                                                                                                    Mice with HFD                                         16 weeks                                         Fecal microbiota transplantation   ↓                                                                                                            

  Tangshen formula                                 Puerariae Radix, Astragalus, Ligustrum lucidum Ait, Ganoderma, Salvia miltiorrhizae Radix Et Rhizoma, Rhei Radix Et Rhizoma                                                                                                                                                                                                                                   Mice with HFD                                         Orally, 16 weeks                                 2.4 g/kg/day                       ↑AMPK/SIRT1                                                                                                  

                                                                                                                                                                                                                                                                                                                                                                                                                 HepG2 cells                                                                                            25, 50, 100 μg/ml                                                                                                                               

  Fenofibrate and Xuezhikang                                                                                                                                                                                                                                                                                                                                                                                     Rat fed with HFD                                      Orally, 6 weeks                                  F (100 mg/kg) and X (300 mg/kg)    ↑PPARα                                                                   ↓TNF-α.                             

  Bangpungtongseong-san                            Talcum, Glycyrrhiza uralensis,Gypsum, Scutellaria baicalensis, Platycodon grandiflorum, Ledebouriella seseloides, Cnidium officinale, Angelica gigas,Paeonia lactiflora,Rheum undulatum, Ephedra sinica, Mentha pulegium, Forsythia koreana, Erigeron canadensis, Schizonepeta tenuifolia, Atractylodes japonica, Gardenia jasminoides, Zingiber officinale   HFD induced obese mice                                12 weeks                                         1.5% w/w                           ↑ mitochondrial function                                                                                     antioxidant
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

![Herbal medicine mediated the key pathological events in the procession of NAFLD. NAFLD, Non-alcoholic fatty liver disease.](fphar-11-00601-g003){#f3}
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